Protective effects of betamipron on renal toxicity during repeated cisplatin administration in rats and protective mechanism

Renal Failure

Volumn 20, Issue 1, 1998, Pages 27-38

  Tokunaga, Jin ^a   Kobayashi, Mie ^a   Kitagawa, Akira ^a   Nakamura, Chizuko ^a   Arimori, Kazuhiko ^a   Nakano, Masahiro ^a  

^a KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Betamipron; Cisplatin; Hippuric acid; Nephrotoxicity; Probenecid; Protective mechanism

Indexed keywords

BETAMIPRON; CISPLATIN; HIPPURIC ACID; PROBENECID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANION TRANSPORT; ARTICLE; BODY WEIGHT; CELL PROTECTION; COMPETITIVE INHIBITION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; KIDNEY INJURY; KIDNEY TUBULE ABSORPTION; LIPID PEROXIDATION; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 0031911678     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229809045087     Document Type: Article

References (33)

1. Sugihara K, Nakano S, Gemba M: Effect of cisplatin on in vitro production of lipid peroxides in rat kidney cortex. Jpn J Pharmacol 44: 71-76, 1987.
2. Hannemann J, Baumann K: Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: different effects of antioxidants and radical scavengers. Toxicology 51:119-132, 1988.
3. Zhang JG, Zhong LF, Zhang M, Xia YX: Protection effects of procaine on oxidative stress and toxicities of renal cortical slices from rats caused by cisplatin in vitro. Arch Toxicol 66: 354-358, 1992.
4. Hayashi T, Watanabe Y, Kumano K, Kitayama R, Mura T, Yasuda T, Saikawa I, Katahira J, Kumada T, Shimizu K: Protective effect of piperacillin against the nephrotoxicity of cisplatin in rats. Antimicrob Agents Chemother 33: 513-518, 1989.
5. Hori R, Ishikawa Y, Takano M, Okano T, Kitazawa S, Inui K: The interaction of cephalosporin antibiotics with renal cortex of rats: accumulation to cortical slices and binding to purified plasma membranes. Biochem Pharmacol 31:2267-2272, 1982.
6. Ross DA, Gale GR: Reduction of the renal toxicity of cis-dichlorodiammineplatinum (II) by probenecid. Cancer Treat Rep 63: 781-787, 1979.
7. Jacobs C, Coleman CN, Rich L, Hirst K, Weiner MW: Inhibition of cis-diamminedichloroplatinum secretion by the human kidney with probenecid. Cancer Res 44: 3632-3635, 1984
8. Jacobs C, Kaubisch S, Halsey J: The use of probenecid as a chemoprotector against cisplatin nephrotoxicity. Cancer 67:1518-1524, 1991.
9. Naganuma H, Tokiwa H, Hirouchi Y, Kawahara Y, Fukushige J, Fukami M, Hirota K, Muramatsu S, Takahagi H, Inui K, Tanigawara Y, Yasuhara M, Hori R, Kuwahara S: Nephoprotective effect and its mechanism of betamipron (1): relationships of renal transport. Chemotherapy 39 (S-3): 166-177, 1991.
10. Naganuma H, Hirouchi Y, Kawahara Y, Inui K, Tanigawara Y, Yasuhara M, Hori R, Kuwahara S: Nephoprotective effect and its mechanism of betamipron (2): relationships of renal excretion. Chemotherapy 39 (S-3): 178-189, 1991
11. Tokunaga J, Kobayashi M, Nakamura C, Kitagawa A, Arimori K, Nakano M: Protective effect of N-benzoyl- β -alanine against cisplatin nephrotoxicity in rats. Renal Failure 18: 225-240, 1996.
12. Tokunaga J, Kobayashi M, Kitagawa A, Nakamura C, Arimori K, Nakano M: Protective effects of N-benzoyl amino acids on cisplatin nephrotoxicity in rats. Biol Pharm Bull 19: 1451-1456, 1996.
13. McGuinness JE, Proctor PH, Demopoulos HB, Hokanson JA, Kirkpatrick DS. Amelioration of cisplatinum nephrotoxicity by orgotein (superoxide dismutase). Physiol Chem Phys 10: 267-277, 1978.
14. Sugihara K, Gemba M: Modification of cisplatin nephrotoxicity by antioxidants. Jpn J Pharmacol 40: 353-355, 1986.
15. Gemba M, Fukuishi N, Nakano S: Effect of N-N-diphenyl-p-phenylenediamine pretreatment on urinary enzyme excretion in cisplatin nephrotoxicity in rats Jpn J Pharmacol 46: 90-92, 1988.
16. Uchiyama M, Mihara M: Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86: 271-278, 1978.
17. Naganuma A, Oda-Urano N, Tanaka T, Imura N: Possible role of hepatic gautathione in transport of methylmercury into mouse kidney Biochem Pharmacol 37: 291-296, 1988.
18. Aebi H: Catalase in vitro Methods Enzymol 105:121-126, 1984.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
20. Lineweaver H, Burk D: The determination of enzyme dissociation constants J Am Chem Soc 56: 658-666, 1934.
21. Dixon M: The determination of enzyme inhibitor constants. Biochem J 55: 170-171, 1953.
22. Sadizuka Y, Shoji T, Takino Y: Change of lipid peroxide levels in rat tissues after cisplatin administration. Toxicol Lett 57: 159-166, 1991.
23. Ketterer B, Coles B, Meyer DJ. The role of glutathione in detoxication. Environ Health Perspect 49: 59-69, 1983
24. Nakano S, Gemba M: Potentiation of cisplatin-induced lipid peroxidation in kidney cortical slices by glutathione depletion. Jpn J Pharmacol 50: 87-92, 1989.
25. Zhang JG, Zhong LF, Zhang M, Ma XL, Xia YX, Lindup WE: Amelioration of cisplatin toxicity in rat renal cortical slices by dithiothreitol in vitro Hum Exp Toxicol 13: 89-93, 1994
26. Litterst CL, Bertolero F, Uozumi J: The role of glutathione and metaliothionem in the toxicity and subcellular biding of cisplatin. In. McBrien DCH, Slater TF (eds): Biochemical Mechanisms of Platinum Antitumor Drugs, IRL Press, Oxford, 1985, pp 227-248
27. Takahagi H, Matsushita Y, Hirata T, Shigeta A, Muramatsu S, Nakajima E, Kawahara Y: Metabolic studies on panipenem/betamipron distribution, metabolism and excretion of panipenem/betamipron in rats and dogs Chemotherapy 39 (S-3): 206-226, 1991.
28. Kiyozumi M, Inoue T, Kojima S, Hidaka S, Tsuruoka M: Protection against cis-diamminedichloroplatinum-induced nephrotoxicity in rats by N-benzyl-D-glucamine dithiocarbamate. Toxicology 67: 41-51, 1991.
29. Rennick BR: Renal tubule transport of organic cations. Am J Physiol 240: F83-F89, 1981.
30. Weiner IM, Mudge GH: Renal tubular mechanisms for excretion of organic acids and bases. Am J Med 36: 743-762, 1964.
31. 2]. Science 218: 1075-1082, 1982.
32. Tokunaga J, Kobayashi M, Kitagawa A, Nakamura C, Arimori K, Nakano M: Betamipron reduces cisplatin nephrotoxicity in rodents without modifying its antileukemic activity in mice. Renal Failure 19:423-436, 1997.
33. Tokunaga J, Kobayashi M, Nakamura C, Kitagawa A, Arimori K, Nakano M: Effects of betamipron on cisplatin nephrotoxicity and its phamacokinetics in rats Biol Pharm Bull 20: 386-391, 1997.